Section of Endocrinology
Professor C E Dent (London) opened the discussion on the diagnosis of hyperparathyroidism by giving a review of the experience gained at University College Hospital on 70 successfully operated patients, thus bringing up to date his earlier review on 40 patients (Dent 1959) . It is our experience, like that of others, that many more patients having parathyroid adenomata present clinically with calcium-containing renal stones than with the clinical picture of hyperparathyroidism with skeletal involvement. The differentiation of these patients from others with renal calculi who do not have hyperparathyroidism is an important matter which may be difficult. They often show only minimal evidence of hypercalcemia and further supportive evidence of the presence of hyperparathyroidism may be of the greatest value.
In this group of patients we have at present two criteria indicating the necessity for further investigation. The first is severe renal tract involvement with calculi or less commonly nephrocalcinosis, especially leading to complications such as renal failure or nephrectomy. The second is suspicion concerning possible abnormality of fasting serum calcium levels. Values between the upper 80 and 95 % confidence limits are regarded as suspicious, those above the 95 % level as definite hypercalczmia. Serum calcium values fluctuate from time to time in patients with hyperparathyroidism, so that hypercalcwmia may be present on some occasions but not on others. These patients do not exhibit hyperphosphatasia, which is often of value in the differentiation of hypercalcemia, and it is found that determination of serum phosphorus values is of poor differential value (see Table 1 ). In half our patients with hyperparathyroidism definite hypercalcemia did not consistently occur and in one patient this was not observed on any occasion. In this and 4 other patients elevation of ionized calcium was not found. A considerable number of patients with renal calculi had suspicious serum calcium levels. The two groups could not be differentiated by the level of the urine calcium on either normal calcium intakes or intakes reduced to 150 mg daily.
Most attention has been given to abnormalities of phosphate metabolism in finally confirming the diagnosis.
Determination of the theoretical renal phosphorus threshold (R.P.Thr.) has the advantage of being independent of the resting serum phosphorus level. It is carried out as previously described (Hyde et al. 1960) . Results with this procedure are shown in Fig 1. In all 13 cases from which parathyroid tumours have now been removed R.P.Thr. was less than 2 mg/100 ml, and in 3 other patients who have not yet had operations for reasons of a non-technical nature. In 11 of these patients creatinine clearance exceeded 60 ml/min, in 2 it was 10 and 41 ml/min respectively. There are several patients with values of R.P.Thr. below 2 mg/100 ml who were not surgically explored on the grounds that there was evidence of an alternative cause for the low threshold. Thus 2 patients, R.P.Thr. 0 7 and 2-0 mg/100 ml, with renal calculi, had renal failure (creatinine clearance 22 and 28 ml/min) and the former may possibly have had secondary hyperparathyroidism. Patients with a tubular phosphate leak associated with renal tubular acidosis would be expected to show a low R.P.Thr., and indeed do so. The miscellaneous groups contained, apart from those with steatorrhcea, patients for control purposes in whom, on clinical grounds, there was no question of the presence of hyperparathyroidism.
In Table 1 are summarized results of abnormalities of phosphorus metabolism in the two groups of patients with hyperparathyroidism and renal calculi. It shows the number of patients in which each parameter was abnormal compared with the total number of patients tested in each case.
In our hands determinations of phosphate/ creatinine clearance ratio (Cp/Ccr) , phosphate excretion index (P.E.I.) and percentage tubular reabsorption of phosphate (T.R.P.) (Thomas et al. 1958) were all less reliable than the R.P.Thr. in the patients with hyperparathyroidism who were operated upon. They also show a number of false positive results in patients with renal calculi who were not considered to have hyperparathyroidism by other criteria or did not have renal tubular acidosis or significant depression ofthe glomerular filtration rate.
The determination of the maximal tubular reabsorption of phosphate (Tmp) (Thompson & Hiatt 1957) has not seemed useful since it is difficult to obtain constant values at varying levels of serum phosphorus.
The R.P.Thr. always returns to normal in ten to fourteen days after parathyroidectomy. In 4 of 6 instances this has not been the case with the P.E.I.
We conclude that the most valuable parameter of abnormal phosphate excretion is the R.P.Thr. In every patient in whom this has been used as an adjunct to the diagnosis of hyperparathyroidism an adenoma has been found, but it can scarcely be expected that in future every patient will be found to have this abnormality. Care must be taken in differentiating patients with renal tubular defects or secondary hyperparathyroidism.
We would like to thank Mr J M Pullan who removed most of the parathyroid tumours, and all those who assisted in the technical investigations.
Dr B E C Nordin (Glasgow) Diagnosis of Primary Hyperparathyroidism
Our screening procedure for the diagnosis of primary hyperparathyroidism starts with the collection of a sample of urine covering a period of about two hours and a sample of blood taken at or near the midpoint of the urine collection. Calcium, phosphorus and creatinine are estimated in blood and urine. This procedure is equally applicable to in-patients and out-patients and reveals not only the plasma calcium and phosphate concentrations but also the urinary calcium/ creatinine ratio and the phosphate/creatinine clearance ratio from which the phosphate excretion index can be calculated.
Plasma calcium: The crucial importance of plasma calcium in the diagnosis cannot be overemphasized but has been dealt with by many other writers. Most workers believe that total calcium varies directly with ionic calcium in primary hyperparathyroidism, but if recent claims to the contrary (Lloyd & Rose 1958 , Freeman & Breen 1960 ) are confirmed the measurement of ultrafiltrable calcium will become indispensable; this is most easily performed by ultracentrifugation (Loken et al. 1960 ). The measurement of ionic calcium (Rose 1957) is of the greatest interest and importance in research but is probably unnecessary in clinical practice because its value is so close to that of the ultrafiltrable fraction. There is an increasing tendency to diagnose primary hyperparathyroidism on plasma calcium values which are at the edge of normality (McGeown & Morrison 1959) . The justification for operation in such cases depends upon the subsequent clinical course. A recent report shows a reduction in the incidence of stones but not the complete elimination of stone formation which might have been expected .
Urinary calcium: The normal calcium/creatinine ratio in random samples of urine ranges from 0 03 to 0-28 (Nordin 1959) . The absolute range is the same in twenty-four-hour collections on an average diet but the twenty-four-hour ratio is more reliable and more reproducible. About half our patients with primary hyperparathyroidism do not have hypercalciuria, possibly because at any given level of plasma calcium the parathyroid hormone tends to reduce calcium clearance (Kleeman et al. 1960 ). The urinary calcium/ creatinine ratio shows some correlation with plasma calcium and is only significantly raised when the plasma calcium is high (Nordin 1961a) . It is clear that stone formation in primary hyperparathyroidism is not solely due to hypercalciuria but may reflect the effect of the hormone upon urine pH .
Plasma and urinary phosphate: Urinary phosphorus normally rises and falls with the concentration of phosphorus in the plasma and the relationship between them has been established by . The phosphate/creatinine clearance ratio (Cp/Ccr) can be calculated from the blood and urine samples as follows:
Cp urine P x plasma Cr Ccr plasma P x urine Cr The normal value can be predicted as follows:
Normal Cp/Ccr=0 055 x Plasma P -0 07 The extent to which the observed value departs from the normal value is called the phosphate excretion index (P.E.I.) the normal range of which is -0 09 to +0 09. The P.E.I. correlates with the plasma calcium concentration (Nordin 1961b) and is a much more reliable index of relative hyperphosphaturia than the phosphate clearance or the tubular reabsorption of phosphate (Nordin 1961b) . We have only encountered one normal P.E.I. in proven hyperparathyroidism; such cases undoubtedly occur and conversely high values are sometimes seen in so-called idiopathic hypercalciuria (Harrison 1960) . This raises the question of what the relationship is between this condition and hyperparathyroidism.
Other procedures: We have found that phosphate excretion is not suppressed by calcium infusion in primary hyperparathyroidism (Nordin 1961a, b) . Other possible tests in primary hyperparathyroidism include X-rays of the skeleton (Barnett , iliac crest biopsy which may show osteoporosis or osteitis fibrosa (Beck & Nordin 1960) , the concentrating power of the kidney (Hellstrom et al. 1958 ) and the acidifying power . The diagnostic value of these procedures is not yet known.
Dr Mary G McGeown (Belfast) The Value of the Calcium Infusion Test, Tests of Renal Tubular Function and Changes in the Serum Proteins in the Diagnosis of Hyperparathyroidism
Hyperparathyroidism is present in about 20°of patients with renal stones, but it is difficult to diagnose in these patients because the elevation of the serum calcium may be slight and tends to fluctuate. Various tests of parathyroid function have been devised, but there has been little information about their value in the diagnosis of hyperparathyroidism. Measurements of the proportion of the filtered phosphate reabsorbed by the renal tubules have proved disappointing as there are many false positives to these tests in patients with renal calculi and other types of hypercalciemia, while in a considerable number of patients with hyperparathyroidism the phosphate clearance is normal , Morgan et al. 1960 , McGeown & Field 1960 . Results obtained with other tests of parathyroid function are considered.
The calcium infusion test: For three days before the infusion the patients ate a standard diet containing 150 mg calcium and 300 mg phosphate. Urine was collected in four-hour periods for the twenty-four hours before, and after the infusion. The infusion consisted of 15 mg of calcium per kg body weight, given as the gluconate, diluted in 400 ml of 50% dextrose, over a period of four hours, beginning at 10 a.m. Comparison of phosphate excretion with a control day is necessary because of diurnal variations in urinary phosphate. Table 1 shows the changes in serum phosphorus and urinary phosphorus after calcium infusion. Patients with hyperparathyroidism are reported to have a lesser rise in serum phosphorus than normal subjects, usually less than 10 mg % (Howard et al. 1953 ). Six of the 16 hyperparathyroid patients had a rise of more than 1-5 mg-% while in 5 it was less than 1 0 mg %, the remainder being intermediate. On the other hand there were 2 apparently euparathyroid subjects with renal stones who showed a rise of less than 1 0 mg %.
Patients with hyperparathyroidism are said to show a rise in urinary phosphate, or only a slight fall, following calcium infusion (Howard et al. 1953) . Only 2 of the hyperparathyroid subjects behaved in this way, while 6 had a fall of more than 40%. Three of the 9 euparathyroid subjects with renal stones showed 'the hyperparathyroid' response.
Three of these patients had hyperparathyroid bone disease. In 2 of them the infusion of calcium scarcely changed the serum calcium while the serum phosphorus fell. The urinary phosphate decreased in all 3 patients.
Tests of renal tubular function: Hyperparathyroid subjects have been reported to show defects of renal tubular function ). Four hyperparathyroid subjects were studied and all were able to achieve a urine concentration at least in the lower normal range after water deprivation for eighteen hours. One produced a very concentrated urine (1,060 m.Osm/l.). When mannitol was infused the minimum concentration of the urine was well above that of plasma in all 4 patients, and the TCH2O was normal or just below normal (+4 0 to +6-8; normal +5 to +7 ml/min.) .
The ability to excrete an acid urine after loading with ammonium chloride was also studied. The dose of ammonium chloride was 0-1 g/kg body weight. Ten out of 11 hyperparathyroid patients produced a urine of pH 5-4 or lower, similar to normal subjects (McGeown 1961). Changes in the serum proteins: Electrophoresis in barbitone buffer at pH 8 -6 was carried out on 28 patients with hyperparathyroidism. In 14 no abnormalities of globulin pattern were present, while the remainder showed a variety of patterns, amongst which the specific pattern reported by Gordan (1960) (rise in 2 and p globulins) did not occur. No electrophoretic pattern emerged which appeared to be associated with hyperparathyroidism.
These three tests of parathyroid function appear to be abnormal in relatively few patients with hyperparathyroidism. They may give misleadingly abnormal results in patients with renal calculi, where the greatest difficulties in making the diagnosis are encountered, also in patients with other types of hypercalcimia. In view of these difficulties in interpreting the results they have no place in the clinical diagnosis of hyperparathyroidism. The time devoted to them would be better used for the estimation of the serum calcium several times in every patient with calcareous renal stones.
Discussion: It may be difficult to distinguish the milk alkali syndrome from primary hyperparathyroidism, as many hyperparathyroid patients have peptic ulcers and have been taking milk and alkali for long periods. The two diseases may resemble each other closely in their biochemical features, including the response of the hypercalcxmia to cortisone. I have investigated 5 patients with peptic ulcers, hypercalcwmia and azotxmia. Three of them were found to have parathyroid adenomata when their necks were explored. One has had his neck explored without a parathyroid adenoma being found, but is still thought to have hyperparathyroidism because the exploration was followed by an abrupt but transient drop in serum calcium and blood urea levels. The fifth patient had a negative exploration and the hypercalcTrmia gradually fell over the following six months, but reappeared when he went back to a diet containing milk. Milk alkali syndrome appears to be very rare in comparison with hyperparathyroidism.
The low serum phosphorus occurring in some patients with steatorrheea is usually explained as being due to secondary hyperparathyroidism. I have had a patient of this type who had a serum calcium of 4-5 mg% and a serum phosphorus of 1*7 mg%. This patient came to autopsy and despite careful search no parathyroid tissue was -found. This does not entirely exclude parathyroid hyperplasia but makes it unlikely, and suggests the possibility that there is some other explanation for the hypophosphatemia in these patients.
Mr G L Fordyce (Northwood, Middlesex) pointed out that the initial sign of hyperparathyroidism was occasionally found in the mouth in the form of an epulis which might grow with extreme rapidity, simulating a sarcomatous lesion. He described briefly 3 cases of this type. Dr Oliver Garrod (London) asked if there was any correlation between the severity of the patients' symptoms and the level of serum calcium.
Professor C E Dent, in reply to this question, said that he thought there was very little, but that each patient had a very exact threshold for symptoms.
Mr W M Keynes (London) asked if there was any method of distinguishing, before operation, between parathyroid hyperplasia and tumour.
Professor Dent replied that there was not.
There followed some discussion as to the existence of two separate parathyroid hormones, to which Professor Dent contributed in particular. He thought that it was well proved now that the same hormone was responsible for calciumraising power and for the renal phosphate excretion. However, he believed that there might be a still undiscovered hormone responsible for producing osteitis fibrosa generalisata.
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Immunological Assay of
Pituitary Hormones
Growth Hormone Assays in Human Serum by Barbara J Boucher MB and A Stuart Mason MD MRCP (London) This paper describes some results obtained using the immunological assay for growth hormone (GH) in human serum described by Read & Stone (1958) and Read (1960) . The results shown are averages of 3 assays done on separate days and the variation has usually lain well within 50 pg each side of the mean.
The assay values in 19 normal subjects, apart from one low value, were found to lie between 100 and 480 pg/l. The mean of the group is 257 (S.D. = 137). A few subjects have been studied over periods of time from two days to one year as shown in Fig 1 and no variation has been found. There is no difference between fasting and nonfasting GH levels.
